A new study comparing GLP-1 analogues, such as semaglutide, to other diabetes drugs finds the popular medications do not increase the risk of thyroid cancer.
Copyright © 2024 HealthDay. All rights reserved.
A new study comparing GLP-1 analogues, such as semaglutide, to other diabetes drugs finds the popular medications do not increase the risk of thyroid cancer.
Copyright © 2024 HealthDay. All rights reserved.
© Copyright 2014-2024 Vicki Doe Fitness · Haywood Doe Consulting Co.,LLC· DBA Vicki Doe Fitness· All Rights Reserved
Leave a Reply